Lonza Group (XSWX:LONN) Forward Dividend Yield % : 0.76% (As of May. 11, 2024)

View and export this data going back to 2002. Start your Free Trial

What is Lonza Group Forward Dividend Yield %?

As of today (2024-05-11), the Forward Annual Dividend Yield of Lonza Group is 0.76%.

As of today (2024-05-11), the Trailing Annual Dividend Yield of Lonza Group is 0.67%.

XSWX:LONN's Forward Dividend Yield % is ranked worse than
77.46% of 71 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.84 vs XSWX:LONN: 0.76

Lonza Group's Dividends per Share for the six months ended in Dec. 2023 was CHF0.00.

During the past 12 months, Lonza Group's average Dividends Per Share Growth Rate was 16.70% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 8.40% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 4.50% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Lonza Group was 10.40% per year. The lowest was 2.90% per year. And the median was 5.90% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Lonza Group's Forward Dividend Yield %

For the Diagnostics & Research subindustry, Lonza Group's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lonza Group's Forward Dividend Yield % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Lonza Group's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Lonza Group's Forward Dividend Yield % falls into.

Lonza Group Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Lonza Group (XSWX:LONN) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Lonza Group Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Lonza Group's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Lonza Group (XSWX:LONN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Lonza Group Ltd (XSWX:LONN) » Definitions » Forward Dividend Yield %

Comparable Companies

Traded in Other Exchanges

LZAGY:USA LZAGF:USA LONN:Mexico LONNz:UK LO3A:Germany LONNE:Switzerland

Address

Muenchensteinerstrasse 38, Basel, CHE, CH-4002

Website

https://www.lonza.com

Lonza Group is a contract development and manufacturing organization, or CDMO. It operates under four segments: small molecules, biologics, cell & gene, and capsules & health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing services throughout the entire lifecycle of a product from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.

Lonza Group (XSWX:LONN) Headlines

No Headlines